Skip to Content
Jump to the top of the page

William Blair Thinking

  • Back of students' heads wearing caps and gowns

    College Was Awesome. Now What?

    College graduation marks the start of a career with new responsibilities and decisions. It can be an exciting time but filled with uncertainty.

    Read more
  • The Impact of Autonomous Vehicles on Auto Insurance

    When cars drive themselves, auto insurance must evolve toward data-driven pricing, shared liability, and new ways to measure risk.

    Read more
  • Tracking the $8 Billion Alzheimer’s Disease Diagnostics Market

    As new Alzheimer’s therapies emerge, diagnostics are becoming an essential infrastructure for screening, treatment decisions, and ongoing monitoring.

    Read more

Our Mission, Vision, and Values

At William Blair, we're committed to our colleagues, our clients, and our communities. Serving our clients starts with the capabilities and collaboration of our team—making our employees our most important asset. When we create an environment where employees perform their best, our delivery for clients will be the best it can be.

Learn more about our mission, vision, and values

Global Community Partners

We are proud of our signature Global Community Partners program, through which employees nominate organizations to receive catalytic financial support and significant volunteerism opportunities every two years.

More about our community partners

Our Latest News

  • Two William Blair Clients Named Middle-Market Deals of the Year by Mergers & Acquisitions

    Congratulations to William Blair clients Commodity & Ingredient Hedging LLC, a portfolio company of Falfurrias Capital Partners, and Stout, a portfolio company of Audax Private Equity, for being recognized on Mergers & Acquisitions’ list of 2026 Mid-Market Deals of the Year.

    Read more
  • Thibaut Has Been Acquired by Quad-C

    William Blair acted as financial advisor to Thibaut, a portfolio company of Norwest Equity Partners, in connection with its sale to Quad-C Management.

    Read more
  • Kailera Therapeutics, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Kailera Therapeutics, Inc. (KLRA $21.47). Kailera is advancing a portfolio of GLP-1-based obesity assets, including mono, dual, and triple agonists with both injectable and oral formats.

    Read more

Join Our Team

Finding, attracting, and developing talented people is the foundation of our success. Learn about the promising career opportunities currently available at William Blair.

Search our job openings
Women sitting outside with a laptop

Delivered to Your Inbox

Stay up-to-date with the latest William Blair news and insights

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures